Could a simple infusion let celiac patients eat gluten again?
Disease control
Completed
This study tested a new drug called TPM502 in 28 adults with celiac disease. The goal was to see if two infusions of TPM502 could safely train the immune system to tolerate gluten, potentially reducing the need for a lifelong gluten-free diet. Participants received either TPM502 …
Phase: PHASE2 • Sponsor: Topas Therapeutics GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC